article thumbnail

How the AI revolution can accelerate early drug discovery

Drug Target Review

He subsequently obtained an MSc in Mathematical Modelling and Scientific Computing from the University of Oxford. From 2005 to 2008 he carried out a DPhil (PhD) at Oxford on nanomaterials for quantum computation, followed by postdoctoral work on the prediction of crystal structures at University College London.

Drugs 105
article thumbnail

Five days in Vermont

Molecular Design

Drug discovery scientists, especially those with backgrounds in computational chemistry and cheminformatics, don’t always appreciate the importance of controlling exposure and the uncertainty in intracellular concentration always makes for a good stock question for speakers and panels of experts.